Nifurtimox reduces N-Myc expression and aerobic glycolysis in neuroblastoma

References

• Philip T, Ladenstein R, Lasset C, Hartmann O, Zucker JM, Pinkerton R, Pearson AD, Klingebiel T, Garaventa A, Kremens B, et al. 1070 myeloablative megatherapy procedures followed by stem cell rescue for neuroblastoma: 17 years of European experience and conclusions. European Group for Blood and Marrow Transplant Registry Solid Tumour Working Party. Eur J Cancer 1997; 33:2130-5; PMID:9516868; http://dx.doi.org/10.1016/S0959-8049(97)00324-9
   PubMed Web of Science ®Google Scholar
• Park JR, Bagatell R, London WB, Maris JM, Cohn SL, Mattay KK, Hogarty M. Children's Oncology Group's 2013 blueprint for research: neuroblastoma. Pediatric Blood Cancer 2013; 60:985-93; PMID:23255319; http://dx.doi.org/10.1002/pbc.24433
   PubMed Web of Science ®Google Scholar
• Brodeur GM, Pritchard J, Berthold F, Carlsen NL, Castel V, Castelberry RP, De Bernardi B, Evans AE, Favrot M, Hedborg F, et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 1993; 11:1466-77; PMID:8336186
   PubMed Web of Science ®Google Scholar
• Castleberry RP, Shuster JJ, Smith EI. The Pediatric Oncology Group experience with the international staging system criteria for neuroblastoma. Member Institutions of the Pediatric Oncology Group. J Clin Oncol 1994; 12:2378-81; PMID:7964953
   PubMed Web of Science ®Google Scholar
• Shimada H, Ambros IM, Dehner LP, Hata J, Joshi VV, Roald B, Stram DO, Gerbing RB, Lukens JN, Matthay KK, et al. The International Neuroblastoma Pathology Classification (the Shimada system). Cancer 1999; 86:364-72; PMID:10421273; http://dx.doi.org/10.1002/(SICI)1097-0142(19990715)86:2%3c364::AID-CNCR21%3e3.0.CO;2-7
   PubMed Web of Science ®Google Scholar
• Ikeda H, Iehara T, Tsuchida Y, Kaneko M, Hata J, Naito H, Iwafuchi M, Ohnuma N, Mugishima H, Toyoda Y, et al. Experience with International Neuroblastoma Staging System and Pathology Classification. Bri J Cancer 2002; 86:1110-6; PMID:11953858; http://dx.doi.org/10.1038/sj.bjc.6600231
   PubMed Web of Science ®Google Scholar
• Zage PE, Sirisaengtaksin N, Liu Y, Gireud M, Brown BS, Palla S, Richards KN, Hughes DP, Bean AJ. UBE4B levels are correlated with clinical outcomes in neuroblastoma patients and with altered neuroblastoma cell proliferation and sensitivity to epidermal growth factor receptor inhibitors. Cancer 2013; 119:915-23; PMID:22990745; http://dx.doi.org/10.1002/cncr.27785
   PubMed Web of Science ®Google Scholar
• Yu F, Gao W, Yokochi T, Suenaga Y, Ando K, Ohira M, Nakamura Y, Nakagawara A. RUNX3 interacts with MYCN and facilitates protein degradation in neuroblastoma. Oncogene 2014; 33:2601-9; PMID:23851507; http://dx.doi.org/10.1038/onc.2013.221
   PubMed Web of Science ®Google Scholar
• Domingo-Fernandez R, Watters K, Piskareva O, Stallings RL, Bray I. The role of genetic and epigenetic alterations in neuroblastoma disease pathogenesis. Pediatr Surg Int 2013; 29:101-19; PMID:23274701; http://dx.doi.org/10.1007/s00383-012-3239-7
   PubMed Web of Science ®Google Scholar
• Mosse YP, Laudenslager M, Longo L, Cole KA, Wood A, Attiyeh EF, Laquaglia MJ, Sennett R, Lynch JE, Perri P, et al. Identification of ALK as a major familial neuroblastoma predisposition gene. Nature 2008; 455:930-5; PMID:18724359; http://dx.doi.org/10.1038/nature07261
   PubMed Web of Science ®Google Scholar
• Haruta M, Kamijo T, Nakagawara A, Kaneko Y. RASSF1A methylation may have two biological roles in neuroblastoma tumorigenesis depending on the ploidy status and age of patients. Cancer Lett 2014; 348:167-76; PMID:24680815; http://dx.doi.org/10.1016/j.canlet.2014.03.022
   PubMed Web of Science ®Google Scholar
• Kaneko Y, Kanda N, Maseki N, Sakurai M, Tsuchida Y, Takeda T, Okabe I, Sakurai M. Different karyotypic patterns in early and advanced stage neuroblastomas. Cancer Res 1987; 47:311-8; PMID:3791218
   PubMed Web of Science ®Google Scholar
• Mosse YP, Deyell RJ, Berthold F, Nagakawara A, Ambros PF, Monclair T, Cohn SL, Pearson AD, London WB, Matthay KK. Neuroblastoma in older children, adolescents and young adults: a report from the International Neuroblastoma Risk Group project. Pediatr Blood Cancer 2014; 61:627-35; PMID:24038992; http://dx.doi.org/10.1002/pbc.24777
   PubMed Web of Science ®Google Scholar
• Brodeur GM, Seeger RC, Schwab M, Varmus HE, Bishop JM. Amplification of N-myc sequences in primary human neuroblastomas: correlation with advanced disease stage. Prog Clin Biol Res 1985; 175:105-13; PMID:3991726
   PubMedGoogle Scholar
• Brodeur GM, Seeger RC, Schwab M, Varmus HE, Bishop JM. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Sci (New York, NY) 1984; 224:1121-4; http://dx.doi.org/10.1126/science.6719137
   Web of Science ®Google Scholar
• Seeger RC, Brodeur GM, Sather H, Dalton A, Siegel SE, Wong KY, Hammond D. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med 1985; 313:1111-6; PMID:4047115; http://dx.doi.org/10.1056/NEJM198510313131802
   PubMed Web of Science ®Google Scholar
• Kim JW, Gao P, Liu YC, Semenza GL, Dang CV. Hypoxia-inducible factor 1 and dysregulated c-Myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1. Mol Cell Biol 2007; 27:7381-93; PMID:17785433; http://dx.doi.org/10.1128/MCB.00440-07
   PubMed Web of Science ®Google Scholar
• Kim JW, Dang CV. Cancer's molecular sweet tooth and the Warburg effect. Cancer Res 2006; 66:8927-30; PMID:16982728; http://dx.doi.org/10.1158/0008-5472.CAN-06-1501
   PubMed Web of Science ®Google Scholar
• Stubbs M, Griffiths JR. The altered metabolism of tumors: HIF-1 and its role in the Warburg effect. Adv Enzyme Regul 2010; 50:44-55; PMID:19896967; http://dx.doi.org/10.1016/j.advenzreg.2009.10.027
   PubMedGoogle Scholar
• Huang LE. Carrot and stick: HIF-alpha engages c-Myc in hypoxic adaptation. Cell Death Differ 2008; 15:672-7; PMID:18188166; http://dx.doi.org/10.1038/sj.cdd.4402302
   PubMed Web of Science ®Google Scholar
• Qing G, Skuli N, Mayes PA, Pawel B, Martinez D, Maris JM, Simon MC. Combinatorial regulation of neuroblastoma tumor progression by N-Myc and hypoxia inducible factor HIF-1alpha. Cancer Res 2010; 70:10351-61; PMID:20961996; http://dx.doi.org/10.1158/0008-5472.CAN-10-0740
   PubMed Web of Science ®Google Scholar
• Saulnier Sholler GL, Kalkunte S, Greenlaw C, McCarten K, Forman E. Antitumor activity of nifurtimox observed in a patient with neuroblastoma. J Pediat Hematol/Oncol 2006; 28:693-5; PMID:17023833; http://dx.doi.org/10.1097/01.mph.0000212994.56812.f2
   PubMed Web of Science ®Google Scholar
• Saulnier Sholler GL, Brard L, Straub JA, Dorf L, Illeyne S, Koto K, Kalkunte S, Bosenberg M, Ashikaga T, Nishi R. Nifurtimox induces apoptosis of neuroblastoma cells in vitro and in vivo. J Pediat Hematol/Oncol 2009; 31:187-93; PMID:19262245; http://dx.doi.org/10.1097/MPH.0b013e3181984d91
   PubMed Web of Science ®Google Scholar
• Boiani M, Piacenza L, Hernandez P, Boiani L, Cerecetto H, Gonzalez M, Denicola A. Mode of action of nifurtimox and N-oxide-containing heterocycles against Trypanosoma cruzi: is oxidative stress involved? Biochem Pharmacol 2010; 79:1736-45; PMID:20178775; http://dx.doi.org/10.1016/j.bcp.2010.02.009
   PubMed Web of Science ®Google Scholar
• Singh RK, Dorf L, DeMartino A, Illenye S, Koto K, Currier EA, Ashikaga T, Kim KK, Brard L, Sholler GL. Oral RKS262 reduces tumor burden in a neuroblastoma xenograft animal model and mediates cytotoxicity through SAPK/JNK and ROS activation in vitro. Cancer Biol Ther 2011; 11:1036-45; PMID:21532338; http://dx.doi.org/10.4161/cbt.11.12.15706
   PubMed Web of Science ®Google Scholar
• Singh RK, Lange TS, Kim KK, Brard L. A coumarin derivative (RKS262) inhibits cell-cycle progression, causes pro-apoptotic signaling and cytotoxicity in ovarian cancer cells. Invest New Drugs 2011; 29:63-72; PMID:19865799; http://dx.doi.org/10.1007/s10637-009-9335-4
   PubMed Web of Science ®Google Scholar
• Saulnier Sholler GL, Bergendahl GM, Brard L, Singh AP, Heath BW, Bingham PM, Ashikaga T, Kamen BA, Homans AC, Slavik MA, et al. A phase 1 study of nifurtimox in patients with relapsed/refractory neuroblastoma. J Pediat Hematol/Oncol 2011; 33:25-30; PMID:21063221; http://dx.doi.org/10.1097/MPH.0b013e3181f47061
   PubMed Web of Science ®Google Scholar
• Saulnier Sholler GL. Study of Nifurtimox to Treat Refractory or Relapsed Neuroblastoma or Medulloblastoma. US. National Institutes of Health, 2008; https://clinicaltrials.gov/ct2/show/NCT00601003?term=nifurtimox+neuroblastoma&rank=2; access 21/Jul/2015
   Google Scholar
• Padro JM, Marson ME, Mastrantonio GE, Altcheh J, Garcia-Bournissen F, Reta M. Development of an ionic liquid-based dispersive liquid-liquid microextraction method for the determination of nifurtimox and benznidazole in human plasma. Talanta 2013; 107:95-102; PMID:23598198; http://dx.doi.org/10.1016/j.talanta.2012.12.050
   PubMed Web of Science ®Google Scholar
• Garcia-Bournissen F, Altcheh J, Panchaud A, Ito S. Is use of nifurtimox for the treatment of Chagas disease compatible with breast feeding? A population pharmacokinetics analysis. Arch Dis Child 2010; 95:224-8; PMID:19948512; http://dx.doi.org/10.1136/adc.2008.157297
   PubMed Web of Science ®Google Scholar
• Basili S, Moro S. Novel camptothecin derivatives as topoisomerase I inhibitors. Exp Opin Ther Pat 2009; 19:555-74; PMID:19441934; http://dx.doi.org/10.1517/13543770902773437
   PubMed Web of Science ®Google Scholar
• Panetta JC, Schaiquevich P, Santana VM, Stewart CF. Using pharmacokinetic and pharmacodynamic modeling and simulation to evaluate importance of schedule in topotecan therapy for pediatric neuroblastoma. Clin Cancer Res 2008; 14:318-25; PMID:18172284; http://dx.doi.org/10.1158/1078-0432.CCR-07-1243
   PubMed Web of Science ®Google Scholar
• Schleiermacher G, Janoueix-Lerosey I, Delattre O. Recent insights into the biology of neuroblastoma. Int J Cancer 2014; 135:2249-61; PMID:25124476; http://dx.doi.org/10.1002/ijc.29077
   PubMed Web of Science ®Google Scholar
• Chen X, Qian Y, Wu S. The Warburg Effect: Evolving Interpretations Of An Established Concept. Free Radic Biol Med 2014; 79:253-63; PMID:25277420; http://dx.doi.org/10.1016/j.freeradbiomed.2014.08.027
   PubMed Web of Science ®Google Scholar
• Maya JD, Cassels BK, Iturriaga-Vasquez P, Ferreira J, Faundez M, Galanti N, Ferreira A, Morello A. Mode of action of natural and synthetic drugs against Trypanosoma cruzi and their interaction with the mammalian host. Comp Biochem Physiol A Mol Integr Physiol 2007; 146:601-20; http://dx.doi.org/10.1016/j.cbpa.2006.03.004
   PubMed Web of Science ®Google Scholar
• Maya JD, Repetto Y, Agosin M, Ojeda JM, Tellez R, Gaule C, Morello A. Effects of nifurtimox and benznidazole upon glutathione and trypanothione content in epimastigote, trypomastigote and amastigote forms of Trypanosoma cruzi. Mol Bioch Parasitol 1997; 86:101-6; PMID:9178272
   PubMed Web of Science ®Google Scholar
• Koto KS, Lescault P, Brard L, Kim K, Singh RK, Bond J, Illenye S, Slavik MA, Ashikaga T, Saulnier Sholler GL. Antitumor activity of nifurtimox is enhanced with tetrathiomolybdate in medulloblastoma. Int J Oncol 2011; 38:1329-41; PMID:21399873
   PubMed Web of Science ®Google Scholar
• McNeil EM, Ritchie AM, Melton DW. The toxicity of nitrofuran compounds on melanoma and neuroblastoma cells is enhanced by Olaparib and ameliorated by melanin pigment. DNA repair 2013; 12:1000-6; PMID:24070777; http://dx.doi.org/10.1016/j.dnarep.2013.08.017
   PubMed Web of Science ®Google Scholar
• Hseu YC, Lee MS, Wu CR, Cho HJ, Lin KY, Lai GH, Wang SY, Kuo YH, Kumar KJ, Yang HL. The chalcone flavokawain B induces G2/M cell-cycle arrest and apoptosis in human oral carcinoma HSC-3 cells through the intracellular ROS generation and downregulation of the Akt/p38 MAPK signaling pathway. J Agric Food Chem 2012; 60:2385-97; PMID:22324429; http://dx.doi.org/10.1021/jf205053r
   PubMed Web of Science ®Google Scholar
• Huang M, Weiss WA. Neuroblastoma and MYCN. Cold Spring Harb Perspect Med 2013; 3:a014415; PMID:24086065; http://dx.doi.org/10.1101/cshperspect.a014415
   PubMed Web of Science ®Google Scholar
• Puissant A, Frumm SM, Alexe G, Bassil CF, Qi J, Chanthery YH, Nekritz EA, Zeid R, Gustafson WC, Greninger P, et al. Targeting MYCN in neuroblastoma by BET bromodomain inhibition. Cancer Dis 2013; 3:308-23; PMID:23430699; http://dx.doi.org/10.1158/2159-8290.CD-12-0418
   PubMed Web of Science ®Google Scholar
• Barone G, Anderson J, Pearson AD, Petrie K, Chesler L. New strategies in neuroblastoma: Therapeutic targeting of MYCN and ALK. Clin Cancer Res 2013; 19:5814-21; PMID:23965898; http://dx.doi.org/10.1158/1078-0432.CCR-13-0680
   PubMed Web of Science ®Google Scholar
• Loesberg C, Van Rooij H, Nooijen WJ, Meijer AJ, Smets LA. Impaired mitochondrial respiration and stimulated glycolysis by m-iodobenzylguanidine (MIBG). Int J Cancer 1990; 46:276-81; PMID:2384275; http://dx.doi.org/10.1002/ijc.2910460223
   PubMed Web of Science ®Google Scholar
• Cornelissen J, Wanders RJ, Van den Bogert C, Van Kuilenburg AB, Elzinga L, Voute PA, Van Gennip AH. Meta-iodobenzylguanidine (MIBG) inhibits malate and succinate driven mitochondrial ATP synthesis in the human neuroblastoma cell line SK-N-BE(2c). Eur J Cancer 1995; 31a:582-6; PMID:7576973; http://dx.doi.org/10.1016/0959-8049(95)00045-K
   PubMed Web of Science ®Google Scholar
• Cornelissen J, Wanders RJ, Van Gennip AH, Van den Bogert C, Voute PA, Van Kuilenburg AB. Meta-iodobenzylguanidine inhibits complex I and III of the respiratory chain in the human cell line Molt-4. Biochem Pharmacol 1995; 49:471-7; PMID:7872952; http://dx.doi.org/10.1016/0006-2952(94)00450-Z
   PubMed Web of Science ®Google Scholar
• Larcher JC, Vayssiere JL, Lossouarn L, Gros F, Croizat B. Regulation of c- and N-myc expression during induced differentiation of murine neuroblastoma cells. Oncogene 1991; 6:633-8; PMID:2030913
   PubMed Web of Science ®Google Scholar
• Hampel T, Bruns M, Bayer M, Handgretinger R, Bruchelt G, Brückner R. Synthesis and biological effects of new hybrid compounds composed of benzylguanidines and the alkylating group of busulfan on neuroblastoma cells. Bioorg Med Chem Lett 2014; 24:2728-33; PMID:24814532; http://dx.doi.org/10.1016/j.bmcl.2014.04.030
   PubMed Web of Science ®Google Scholar
• Rudolph G, Schilbach-Stuckle K, Handgretinger R, Kaiser P, Hameister H. Cytogenetic and molecular characterization of a newly established neuroblastoma cell line LS. Hum Genet 1991; 86:562-6; PMID:2026421; http://dx.doi.org/10.1007/BF00201542
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (San Diego, Calif) 2001; 25:402-8; http://dx.doi.org/10.1006/meth.2001.1262
   PubMed Web of Science ®Google Scholar
• Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008; 3:1101-8; PMID:18546601; http://dx.doi.org/10.1038/nprot.2008.73
   PubMed Web of Science ®Google Scholar
• Tumilowicz JJ, Nichols WW, Cholon JJ, Greene AE. Definition of a continuous human cell line derived from neuroblastoma. Cancer Res 1970; 30:2110-8; PMID:5459762
   PubMed Web of Science ®Google Scholar
• Seeger RC, Rayner SA, Banerjee A, Chung H, Laug WE, Neustein HB, Benedict WF. Morphology, growth, chromosomal pattern and fibrinolytic activity of two new human neuroblastoma cell lines. Cancer Res 1977; 37:1364-71; PMID:856461
   PubMed Web of Science ®Google Scholar
• Rostomily RC, Bermingham-McDonogh O, Berger MS, Tapscott SJ, Reh TA, Olson JM. Expression of neurogenic basic helix-loop-helix genes in primitive neuroectodermal tumors. Cancer Res 1997; 57:3526-31; PMID:9270024
   PubMed Web of Science ®Google Scholar
• Kato H, Okamura K, Kurosawa Y, Kishikawa T, Hashimoto K. Characterization of DNA rearrangements of N-myc gene amplification in three neuroblastoma cell lines by pulsed-field gel electrophoresis. FEBS Lett 1989; 250:529-35; PMID:2753147; http://dx.doi.org/10.1016/0014-5793(89)80790-2
   PubMed Web of Science ®Google Scholar
• Thiele CJ. Neuroblastoma: In (Ed.) Masters. J Hum Cell Culture 1998; 1:21-53; http://dx.doi.org/10.1007/0-306-46872-7_2
   Google Scholar
• Biedler JL, Helson L, Spengler BA. Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res 1973; 33:2643-52; PMID:4748425
   PubMed Web of Science ®Google Scholar